The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of stereotactic radiation and sacituzumab govitecan with zimberelimab in the management of metastatic triple negative breast cancer with brain metastases.
 
Kamran A. Ahmed
Consulting or Advisory Role - Castle Biosciences
Research Funding - Genentech; Gilead Sciences; Lilly
 
Youngchul Kim
No Relationships to Disclose
 
Michelle DeJesus
No Relationships to Disclose
 
Daniel Eli Oliver
No Relationships to Disclose
 
Matthew Mills
Employment - Moffitt Cancer Center
 
Rajesh Nair
No Relationships to Disclose
 
Avan J. Armaghani
No Relationships to Disclose
 
Ricardo L Costa
Stock and Other Ownership Interests - Dare Bioscience; Spero Therapeutics
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Pfizer; Sermonix Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Pfizer; Sermonix Pharmaceuticals
 
Kimberley T Lee
No Relationships to Disclose
 
Loretta S. Loftus
Stock and Other Ownership Interests - Lilly
 
Tracey L. O'Connor
No Relationships to Disclose
 
Hatem Hussein Soliman
Consulting or Advisory Role - AstraZeneca; GE Healthcare; Lilly; Novartis; Puma Biotechnology; Seagen; Sermonix Pharmaceuticals
Speakers' Bureau - Merck
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - Celeyad licensing agreement (Inst)
 
Aixa Elena Soyano Muller
Honoraria - FLASCO; OncLive/MJH Life Sciences
Consulting or Advisory Role - Lilly; Novartis
 
Michael A. Vogelbaum
Stock and Other Ownership Interests - Infusion Therapeutics
Consulting or Advisory Role - Midatech Pharma; Olympus; SERVIER
Research Funding - Celgene (Inst); Denovo Biopharma (Inst); Infusion Therapeutics (Inst); Oncosynergy (Inst)
Patents, Royalties, Other Intellectual Property - Patent for drug delivery devices, assigned to Moffitt Cancer Center.; Patents for drug delivery devices for the brain
 
Peter A. J. Forsyth
Honoraria - Abbvie; BTG; Novocure; Stanford University Health, Department of Neurology
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; BTG; Midatech Pharma; National Brain Tumor Society; Novartis; Novocure; Tocagen; ZIOPHARM Oncology
Research Funding - Bankhead-Coley Cancer Research; Bristol-Myers Squibb; Department of Defense; Florida Academic Cancer Center Alliance; Florida Breast Cancer Foundation; MSCCoE; NIH/NCI; Pfizer
Travel, Accommodations, Expenses - Abbvie; Bayer; Bristol-Myers Squibb; BTG; Inovio Pharmaceuticals; National Cancer Research Institute (NCRI); NCCN; NCI; NIH; Physical Sciences Oncology Network
 
John Arrington
No Relationships to Disclose
 
Marilin Rosa
Consulting or Advisory Role - AstraZeneca
 
Michael Yu
Honoraria - Elsevier; Guidepoint Global; UpToDate
Consulting or Advisory Role - Novocure
Research Funding - Bristol-Myers Squibb/Sanofi (Inst); Merck (Inst)
 
Hyo S. Han
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Immunomedics; Novartis
Research Funding - Abbvie (Inst); Arvinas (Inst); Celcuity (Inst); Department of Defense (Inst); G1 Therapeutics (Inst); GlaxoSmithKline (Inst); Marker Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Phoenix Pharmaceuticals (Inst); Pionyr (Inst); QuantumLeap Health (Inst); Seagen (Inst); Senhwa Biosciences (Inst); Zymeworks (Inst)